Table 2. Selected KEGG gene pathways relating to cell communication and environmental information processing that were significantly enriched compared to HIV negative controls.
Time | Term | KID | Adjusted P | OR | Expected count | Observed count | |
---|---|---|---|---|---|---|---|
Control—ABC | 6 m | ECM-receptor interaction | 4512 | 0.036 | 1.80 | 16 | 25 |
Focal adhesion | 4510 | 0.036 | 1.40 | 41 | 53 | ||
Tight junctions | 4530 | 0.043 | 1.50 | 24 | 32 | ||
Adherence Junction | 4520 | 0.043 | 1.62 | 16 | 23 | ||
Control—ABC | 18–24 m | Wnt signalling pathway | 4310 | 0.045 | 1.49 | 27.1 | 36 |
Adherence Junction | 4520 | 0.045 | 1.65 | 16.2 | 23 | ||
ECM-receptor interaction | 4512 | 0.046 | 1.65 | 16.2 | 23 | ||
Control—AZT | 6m | Cytokine-cytokine receptor interaction | 4060 | 0.03 | 3.02 | 2.17 | 6 |
Control – AZT | 18–24 m | Neuroactive ligand-receptor interaction | 4080 | <0.0001 | 2.78 | 26.1 | 54 |
Cytokine-cytokine receptor interaction | 4060 | 0.019 | 1.61 | 25 | 36 | ||
ECM-receptor interaction | 4512 | 0.034 | 1.78 | 11.5 | 18 | ||
Control—TDF | 6 m | Cytokine-cytokine receptor interaction | 4060 | 0.038 | 6.90 | 0.58 | 3 |
Control—TDF | 18–24 m | Neuroactive ligand-receptor interaction | 4080 | <0.0001 | 2.67 | 25 | 51 |
Cytokine-cytokine receptor interaction | 4060 | 0.01 | 1.76 | 24 | 37 | ||
ECM-receptor interaction | 4512 | 0.021 | 2.03 | 11.1 | 19 | ||
VEGF signalling pathway | 4370 | 0.029 | 1.88 | 10.4 | 17 | ||
WNT signalling pathway | 4310 | 0.04 | 1.54 | 18.5 | 26 |
KID = Kegg identity; OR = odds ratio; Time = time after treatment